Eloxx Pharmaceuticals Inc.
ELOX | NASDAQ
$13.45
+$0.27 (+2.05%)
At close: Oct 30, 2026, 4:00 PM ET
$13.79
+$0.34 (+2.53%)
Pre-market:
Nov 2, 2026, 7:12 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q1 2025 Mar 31, 2025 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -8.26M | -3.75M | -1.71M | -14.16M | -18.08M | -24.36M | -41.84M | -44.21M | -69.65M | -66.73M | -60.76M | -57.5M | -29.33M |
Depreciation & Amortization | n/a | n/a | n/a | 559K | 560K | 504K | 718K | 808K | 1.01M | 960K | 904K | 768K | 598K |
Stock-Based Compensation | 141K | 46K | 20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -1.37M | -2.01M | 412K | -860K | -669K | -474K | 901K | 751K | -1.06M | -715K | -1.62M | -1.58M | -813K |
Other Non-Cash Items | -294K | -49K | 261K | 2M | 2.6M | 2.71M | 4.62M | 5.59M | 31.7M | 31.8M | 31.49M | 31.27M | 6.52M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.83M | -1.7M | 2.63M | -727K | -907K | -2.37M | 387K | 1.06M | 137K | -1.04M | -1.36M | -1.95M | -1.72M |
Operating Cash Flow | -10.24M | -5.45M | 1.2M | -12.33M | -15.83M | -23.51M | -36.12M | -36.76M | -36.81M | -35M | -29.74M | -27.41M | -23.93M |
Capital Expenditures | n/a | n/a | n/a | n/a | -48K | -55K | -86K | -107K | -100K | -89K | -69K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | 258K | 25K | 11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.75M | 18M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.15M | 2.15M | 2.15M | 2.15M | 3K |
Investing Cash Flow | n/a | n/a | n/a | 258K | -23K | -44K | -86K | -107K | 2.05M | 2.06M | 2.08M | 8.9M | 18M |
Debt Repayment | n/a | n/a | -865K | -7.72M | -7.5M | -7.5M | -36K | 2.99M | 1.74M | 491K | -723K | -5M | -4.61M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 67.29M | 6.99M | n/a | 2.17M | 1.5M | 1.5M | 8.38M | 7.19M | 7.04M | 2.56M | 2.68M | 2.36M | 2.91M |
Financial Cash Flow | 67.42M | 7.03M | -865K | -2.4M | -4.57M | -6M | 8.34M | 10.2M | 56.53M | 50.79M | 49.7M | 45.09M | -1.69M |
Net Cash Flow | 56.97M | 1.38M | 339K | -14.47M | -20.42M | -29.55M | -27.86M | -26.67M | 21.76M | 17.84M | 22.03M | 26.58M | -7.62M |
Free Cash Flow | -10.24M | -5.45M | 1.2M | -12.33M | -15.87M | -23.56M | -36.2M | -36.86M | -36.91M | -35.09M | -29.81M | -27.41M | -23.93M |
Adj. Free Cash Flow | -10.38M | -5.5M | 1.18M | -12.33M | -15.87M | -23.56M | -36.2M | -36.86M | -36.91M | -35.09M | -29.81M | -27.41M | -23.93M |
Maintenance CapEx | n/a | n/a | n/a | -48K | -55K | -66K | -86K | -107K | -100K | -89K | -69K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -12.49M | -9.76M | -11.13M | -19.32M | -25.63M | -33.06M | -36.2M | -36.86M | -36.91M | -35.09M | -29.81M | -27.41M | -23.93M |
Add to Watchlist
Select watchlists to add or remove ELOX